Beijing Jiacheng Biopharmaceutical Technology Development

Beijing Jiacheng Biomedical Technology Development Co., Ltd. (also known as Beijing Join Chain Medicine) is a Chinese biopharmaceutical company founded in 2001 and based in Beijing. The company is a core component of the Shouyao Holdings group and focuses on the development of small molecule drugs for pain, urogenital, and infectious diseases. Its clinical pipeline includes JC005 for erectile dysfunction and several analgesics like SY002 and JC002, which are currently in Phase 1 or pharmacokinetic studies. Additionally, the company holds marketing authorizations for commercial products such as ketoconazole suppositories and dexibuprofen. Beijing Jiacheng is led by Li Wenjun, the founder of Shouyao Holdings, and serves as a key platform for the group's intellectual property and clinical development activities.